Skip to main content
Livermore
Livermore
ZHEN

Damora Therapeutics, Inc.

DMRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001800315

In the last 90 days, Damora Therapeutics, Inc. insiders filed 1 open-market purchase and 1 sale; 104 institutions reported holding it in 13F filings for Q2 2026, worth $1.67B in total; Viking Global Investors is the only superinvestor holding it.

Q1 2026 vs. Q4 2025

How the institutions holding Damora Therapeutics, Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of DMRA: Q4 2025 compared with Q1 2026
MeasureQ4 2025Of which not filed for Q1 2026Q1 2026Change
Holders18165+48
Shares1.11M18.2K56.0M+54.9M (+5,039.2%)
Value$65.5M$419.9K$1.45B+$1.39B (+2,130.1%)

1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (51)

Institutions that held Damora Therapeutics, Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to DMRA in Q1 2026
InstitutionSharesValue% of portfolio
Fairmount Funds Management LLC8,713,000$225.7M16.30%
Avoro Capital Advisors LLC3,783,000$98.0M0.97%
VR Adviser, LLC3,603,595$93.3M3.48%
FCPM III Services B.V.2,441,000$63.2M8.75%
Ra Capital Management, L.P.2,399,310$62.1M0.66%
Viking Global Investors LPSuperinvestorViking Global Investors2,311,082$59.9M0.17%
Bellevue Group AG2,298,000$59.5M1.42%
Commodore Capital LP1,939,000$50.2M2.91%
Cormorant Asset Management, LP1,525,000$39.5M1.99%
Balyasny Asset Management LLC1,448,000$37.5M0.07%
AH Capital Management, L.L.C.1,236,157$32.0M2.48%
Perceptive Advisors LLC1,223,000$31.7M0.63%
Wellington Management Group LLP1,058,000$27.4M0.01%
Siren, L.L.C.900,000$23.3M0.65%
Braidwell LP894,846$23.2M0.77%
Vestal Point Capital, LP600,000$15.5M0.43%
Blackstone Group Inc.503,522$13.0M0.05%
Millennium Management LLC471,646$12.2M0.01%
Affinity Asset Advisors, LLC450,000$11.7M0.68%
Qube Research & Technologies Ltd282,436$7.32M0.01%
ADAR1 Capital Management, LLC279,000$7.23M0.43%
Nantahala Capital Management, LLC278,000$7.20M0.45%
Vanguard Capital Management LLC201,847$5.23M0.00%
State Street Corp183,922$4.76M0.00%
Marshall Wace, LLP169,818$4.40M0.00%
Kalehua Capital Management LLC139,000$3.60M2.55%
Ameriprise Financial Inc117,675$3.05M0.00%
Seven Fleet Capital Management LP101,248$2.62M0.82%
Vanguard Fiduciary Trust Co96,664$2.50M0.00%
Goldman Sachs Group Inc88,336$2.29M0.00%
Hudson Bay Capital Management LP76,338$1.98M0.01%
HRT Financial LP72,113$1.87M0.00%
Brevan Howard Capital Management LP55,232$1.43M0.01%
Northern Trust Corp38,882$1.01M0.00%
Landscape Capital Management, L.L.C.24,456$633.4K0.04%
Squarepoint Ops LLC23,458$607.6K0.00%
Barclays PLC22,034$570.7K0.00%
Catalyst Funds Management Pty Ltd17,293$447.9K0.08%
Charles Schwab Investment Management Inc12,500$323.8K0.00%
Jane Street Group, LLC11,420$295.8K0.00%
Schonfeld Strategic Advisors LLC10,824$280.3K0.00%
Susquehanna International Group, LLP9,770$253.0K0.00%
XTX Topco Ltd9,728$252.0K0.00%
Cannon Global Investment Management, LLC9,300$240.9K0.58%
Y-Intercept (Hong Kong) Ltd7,921$205.2K0.00%
Vanguard Global Advisers, LLC6,263$162.2K0.00%
BNP Paribas Arbitrage, SA6,194$160.4K0.00%
Persistent Asset Partners Ltd5,338$138.3K0.05%
Mirae Asset Global ETFs Holdings Ltd.353$8.57K0.00%
Harbour Investments, Inc.40$1.04K0.00%
Royal Bank of Canada7$00.00%

Sold out (3)

Institutions that held Damora Therapeutics, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of DMRA in Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Jain Global LLC120,566$2.77M
Sigma Planning Corp14,500$333.6K
SHP Wealth Management25$575

Not filed for Q1 2026 yet (1)

Institutions that held Damora Therapeutics, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DMRA in Q4 2025 that haven't filed for Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Vanguard Group Inc18,247$419.9K